# Magnetic Seizure Therapy for Schizophrenia - Trial

> **NCT06672588** · NA · RECRUITING · sponsor: **Centre for Addiction and Mental Health** · enrollment: 80 (estimated)

## Conditions studied

- Treatment Resistant Schizophrenia
- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DEVICE:** Magnetic Seizure Therapy (MST)
- **DEVICE:** Electroconvulsive Therapy (ECT)

## Key facts

- **NCT ID:** NCT06672588
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-22
- **Primary completion:** 2028-11
- **Final completion:** 2028-11
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06672588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06672588, "Magnetic Seizure Therapy for Schizophrenia - Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06672588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*